Ohio Rep. David Taylor purchased between $3,003 and $45,000 in Amgen shares.

Oct 2, 2026, 11:09 AM ETPaperworkRead the original at Benzinga

Neutral

Amgen's story reports a lawmaker's purchase but lists different value ranges in its opening and trade table. It gives no company news, so the purchase does not change Amgen's outlook.

AMGN · Amgen

AI read · Neutral

The AI's read

An elected official's choice can draw attention, but it does not show what is changing in Amgen's business. The article also warns readers not to rely on such trades alone. Its two different purchase ranges add uncertainty, so this report does not change Amgen's outlook.

Get alerts for AMGN

Follow Amgen (AMGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AMGN

Free on the App Store and Google Play, or on the web.